Scinai Immunotherapeutics Ltd.
SCNI
$2.44
-$0.0734-2.92%
NASDAQ
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 284.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 284.00K | -- | -- | -- | -- |
| Cost of Revenue | 448.00K | -- | -- | -- | -- |
| Gross Profit | -164.00K | -- | -- | -- | -- |
| SG&A Expenses | 519.00K | 1.21M | 968.00K | 1.14M | 1.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 124.00K | -9.00K | -- | -- | -- |
| Total Operating Expenses | 2.31M | 1.82M | 2.10M | 2.60M | 3.19M |
| Operating Income | -2.03M | -1.82M | -2.10M | -2.60M | -3.19M |
| Income Before Tax | -2.32M | -2.33M | -3.11M | -3.76M | -3.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.32M | -2.33M | -3.11M | -3.76M | -3.52M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.32M | -2.33M | -3.11M | -3.76M | -3.52M |
| EBIT | -2.03M | -1.82M | -2.10M | -2.60M | -3.19M |
| EBITDA | -1.53M | -1.74M | -1.96M | -2.45M | -3.05M |
| EPS Basic | -14.57K | -31.03K | -26.49K | -44.53K | -43.42K |
| Normalized Basic EPS | -2.28 | -4.85 | -- | -6.96 | -6.78 |
| EPS Diluted | -14.57K | -38.41K | -26.49K | -44.53K | -48.00K |
| Normalized Diluted EPS | -2.28 | -4.85 | -- | -6.96 | -6.78 |
| Average Basic Shares Outstanding | 637.60K | 300.40K | 469.20K | 338.00K | 323.80K |
| Average Diluted Shares Outstanding | 100.00 | 0.00 | 100.00 | 0.00 | 0.00 |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |